Focus on consolidation could help them strengthen their position in the competitive pharmaceutical industry, potentially driving expansion and improving efficiencies
The company is making its mark through strategic initiatives, promising to become a significant presence in the evolving pharmaceutical sector
This strong performance was primarily on account of a one-time gain from the strategic collaboration between Biocon Biologics and Eris Lifesciences.
The expiry date of almost all strips is rubber stamped vanish in a matter of 3 to 4 months, making the remaining tablets waste for subsequent use before expire date
Highlighting fully integrated organization, robust portfolio, and strategic priorities to drive long-term sustainable growth
he company posted total income during Q2 FY24 at Rs. 12.86 crore
The company has reported total income of Rs. 115.37 crores during the period ended June 30, 2023
Aim is to predict novel catalysts using machine learning (ML) and artificial intelligence (AI) techniques
The patent was granted for creating a green catalyst for one of the world's most significant chemical reactions
This will give either party customers access enzyme expertise and assets, resulting in cost-effective, green processing for API manufacturing.
Subscribe To Our Newsletter & Stay Updated
